Get started
Author

Gillian M. Mackie

Observed names: Gillian M Mackie, Mackie, Gillian M, Mackie, Gillian M.
ORCID: 0000-0001-7758-6570
Observed ORCID: 0000-0001-7758-6570
OpenAlex ID: A5041406067
PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection
2023 · Daniel Fisch, Moritz M. Pfleiderer, et al. · Science · 52
Nur77-Tempo mice reveal T cell steady state antigen recognition
2022 · Thomas A E Elliot, Emma K Jennings, et al. · Discovery Immunology · 25
Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity
2024 · Alastair Copland, Gillian M Mackie, et al. · EMBO Molecular Medicine · 19
PDF
1,25‐Dihydroxyvitamin D3 suppresses CD4 + T‐cell effector functionality by inhibition of glycolysis
2022 · Emma L. Bishop, Nancy H. Gudgeon, et al. · Immunology · 19
PDF
LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity
2022 · Giuseppe Bombaci, Mayuresh Anant Sarangdhar, et al. · Life Science Alliance · 16
PDF
Bacterial cancer therapy in autochthonous colorectal cancer affects tumor growth and metabolic landscape
2021 · Gillian M. Mackie, Alastair Copland, et al. · JCI Insight · 14
PDF
Attenuated Salmonella typhimurium cancer therapy has direct effects on the tumor epithelium in colorectal cancer
2019 · Kendle M. Maslowski, Masumi Takahashi, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Ageing influences tumour–niche interactions: Implications for metastatic dormancy, reawakening and recurrence
2026 · Gillian M. Mackie, Frances K. Turrell · Current Opinion in Cell Biology · 2
LRR protein RNH1 dampens the inflammasome activation and is associated with adverse clinical outcomes in COVID-19 patients
2021 · Giuseppe Bombaci, Mayuresh Anant Sarangdhar, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Works count: 11
Citation count: 150
H-index: 6
I10-index: 6
Year
Topic
Type